Systemic photochemotherapy decreases the expression of IFN-γ, IL-12p40 and IL-23p19 in psoriatic plaques

European Journal of Dermatology

Volumn 21, Issue 1, 2011, Pages 53-57

  Ravić Nikolić, Ana ^a   Radosavljević, Gordana ^a   Jovanović, Ivan ^a   Zdravković, Nemanja ^a   Mitrović, Slobodanka ^a   Pavlović, Sladjana ^a   Arsenijević, Nebojša ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Interferon ; Interleukins; PASI; Psoriasis; PUVA therapy

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 23P19; PSORALEN;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PSORIASIS VULGARIS; PUVA; SYSTEMIC THERAPY; TH17 CELL; TREATMENT RESPONSE; DERMIS; EPIDERMIS; METABOLISM; MIDDLE AGED; PSORIASIS; SKIN;

ADULT; AGED; DERMIS; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23 SUBUNIT P19; MIDDLE AGED; PSORIASIS; PUVA THERAPY; SKIN; YOUNG ADULT;

EID: 79957524037     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1199     Document Type: Article

References (28)

1. 1. Expert Rev Dermatol 2007; 2: 69-78.
2. Pietrzak AT, Zalewska A, Chodorowska G, et al. Cytokines and anticytokines in psoriasis. Clin Chim Acta 2008; 394: 7-21.
3. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64: 30-6.
4. Stetsko D, Sauber DN. IL-12 and IL-23 in health and disease. Expert Rev Clin Immunol 2008; 4: 301-3.
5. Torti DC, Feldman SR. Interleukin-12, interleukin-23, and psoriasis: Current prospects. J Am Acad Dermatol 2007; 57: 1059-68.
6. Koga T, Duan H, Urabe K, Masutaka F. In situ localization of IFNgamma-positive cells in psoriatic lesional epidermis. Eur J Dermatol 2002; 12: 20-3.
7. Oppmann B, Lesley R, Blow B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715-25.
8. Blauvelt A. T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol 2008; 128: 1064-7.
9. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-41.
10. Kryczek I, Bruce AT, Gudjonsson JE, et al. Induction of IL-17+ T cell trafficking and development by IFN-γ: mechanism and pathological relevance in psoriasis. J Immunol 2008; 181: 4733-41.
11. Acosta-Rodrigues EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing cells. Nat Immunol 2007; 8: 639-46.
12. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361: 496-509.
13. Sabat R, Philipp S, Höflich C, et al. Immunopathogenesis of psoriasis. Exp Dermatol 2007; 16: 779-98.
14. Johnson-Huang LM, Suarez-Farinas M, Sullivan-Whalen M, et al. Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques. J Invest Dermatol 2010; 130: 2654-63.
15. Piskin G, Sylva-Steenland RMR, Bos JD, Teunissen MBM. In vitro and in situ expression of IL-23 by kertinocytes in healthy skin and psoriatic lesions: enhanced expression in psoriatic skin. J Immunol 2006; 176: 1908-15.
16. Weichenthal M, Schwarz T. Phototherapy: How does UV work?. Photodermatol Photoimmunol Photomed 2005; 21: 260-6.
17. Stern RS. Psoralen and Ultraviolet A Light Therapy for Psoriasis. N Eng J Med 2007; 357: 682-90.
18. Erkin G, Ǔgur Y, Gürer CK, et al. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque. J Clin Pathol 2006; 34: 213-9.
19. Baker BS. Recent advances in psoriasis: the role of the immune system. London: Imperial College Press, 2000, p. 50-1.
20. Coimbra S, Oliveira H, Reis F, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol 2010; 163: 1282-90.
21. Piskin G, Sylva-Steenland RMR, Bos JD, Teunissen MBM. T cells in psoriatic lesional skin that survive conventional therapy with NBUVB radiation display reduced IFN-γ expression. Arch Dermatol Res 2004; 295: 509-16.
22. Piskin G, Tursen U, Sylva-Steenland RMR, Bos JD, Teunissen MBM. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-γ inducers-IL-12, IL-18 and IL-23. Exp Dermatol 2004; 13: 764-72.
23. Toichi E, Torres G, McCormick TS, et al. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol 2006; 177: 4917-26.
24. Chamian F, Lowes MA, Lin SL, et al. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci 2005; 102: 2075-80.
25. Lowes MA, Chamian F, Abello MV, et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci 2005; 102: 19057-62.
26. Cordiali-Fei P, Trento E, D'Agosto G, et al. Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions. Ann N Y Acad Sci 2007; 1110: 578-89.
27. Cordiali-Fei P, Trento E, D'Agosto G, et al. Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha. J Autoimmune Dis 2006; 3: 5.
28. Singh TP, Schön MP, Wallbrecht K, et al. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol 2010; 184: 7257-67.